このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Amedisys 過去の業績
過去 基準チェック /06
Amedisysの収益は年間平均-20.2%の割合で減少していますが、 Healthcare業界の収益は年間 増加しています。収益は年間5.6% 4.4%割合で 増加しています。
主要情報
-20.2%
収益成長率
-20.5%
EPS成長率
| Healthcare 業界の成長 | 8.5% |
| 収益成長率 | 4.4% |
| 株主資本利益率 | -1.9% |
| ネット・マージン | -0.9% |
| 前回の決算情報 | 31 Mar 2024 |
最近の業績更新
Recent updates
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?
Apr 10
Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around
Feb 10At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jan 03A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Dec 16Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal
Nov 12Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?
Sep 19An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued
Sep 04Amedisys: ROIC, Tangible Book Value Each Softening
Aug 24Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement
Aug 04Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates
Jul 27We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jun 04Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled
May 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?
Apr 20Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?
Apr 06Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue
Jan 19Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
Dec 03These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Jul 23Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity
Jul 18Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive
Jun 28It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package
Jun 02Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
May 24収支内訳
収支内訳
Amedisys の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 24 | 2,251 | -21 | 780 | 0 |
| 31 Dec 23 | 2,236 | -10 | 780 | 0 |
| 30 Sep 23 | 2,228 | 3 | 793 | 0 |
| 30 Jun 23 | 2,229 | 2 | 789 | 0 |
| 31 Mar 23 | 2,234 | 112 | 763 | 0 |
| 31 Dec 22 | 2,223 | 119 | 754 | 0 |
| 30 Sep 22 | 2,220 | 121 | 745 | 0 |
| 30 Jun 22 | 2,216 | 140 | 736 | 0 |
| 31 Mar 22 | 2,222 | 191 | 723 | 0 |
| 31 Dec 21 | 2,214 | 209 | 711 | 0 |
| 30 Sep 21 | 2,206 | 220 | 1,033 | 0 |
| 30 Jun 21 | 2,196 | 247 | 911 | 0 |
| 31 Mar 21 | 2,117 | 202 | 785 | 0 |
| 31 Dec 20 | 2,072 | 184 | 668 | 0 |
| 30 Sep 20 | 2,021 | 166 | 216 | 0 |
| 30 Jun 20 | 1,972 | 128 | 214 | 0 |
| 31 Mar 20 | 1,980 | 127 | 219 | 0 |
| 31 Dec 19 | 1,956 | 127 | 608 | 0 |
| 30 Sep 19 | 1,889 | 127 | 207 | 0 |
| 30 Jun 19 | 1,812 | 124 | 197 | 0 |
| 31 Mar 19 | 1,731 | 123 | 189 | 0 |
| 31 Dec 18 | 1,663 | 119 | 185 | 0 |
| 30 Sep 18 | 1,626 | 88 | 181 | 0 |
| 30 Jun 18 | 1,583 | 71 | 178 | 0 |
| 31 Mar 18 | 1,546 | 42 | 178 | 0 |
| 31 Dec 17 | 1,511 | 30 | 177 | 0 |
| 30 Sep 17 | 1,474 | 43 | 181 | 0 |
| 30 Jun 17 | 1,456 | 40 | 187 | 0 |
| 31 Mar 17 | 1,438 | 46 | 190 | 0 |
| 31 Dec 16 | 1,419 | 37 | 196 | 0 |
| 30 Sep 16 | 1,391 | 41 | 198 | 0 |
| 30 Jun 16 | 1,358 | 38 | 193 | 0 |
| 31 Mar 16 | 1,313 | 38 | 188 | 0 |
| 31 Dec 15 | 1,266 | -3 | 173 | 0 |
| 30 Sep 15 | 1,230 | -7 | 158 | 0 |
| 30 Jun 15 | 1,204 | -7 | 149 | 0 |
| 31 Mar 15 | 1,193 | -10 | 142 | 0 |
| 31 Dec 14 | 1,188 | 13 | 147 | 0 |
| 30 Sep 14 | 1,191 | -4 | 153 | 0 |
| 30 Jun 14 | 1,192 | -103 | 161 | 0 |
| 31 Mar 14 | 1,203 | -109 | 167 | 0 |
| 31 Dec 13 | 1,233 | -93 | 170 | 0 |
| 30 Sep 13 | 1,278 | -191 | 176 | 0 |
| 30 Jun 13 | 1,340 | -90 | 182 | 0 |
質の高い収益: AMEDは現在利益が出ていません。
利益率の向上: AMEDは現在利益が出ていません。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: AMEDは利益が出ておらず、過去 5 年間で損失は年間20.2%の割合で増加しています。
成長の加速: AMEDの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: AMEDは利益が出ていないため、過去 1 年間の収益成長をHealthcare業界 ( 15.1% ) と比較することは困難です。
株主資本利益率
高いROE: AMEDは現在利益が出ていないため、自己資本利益率 ( -1.86% ) はマイナスです。